Thiamine injection (vitamin B1)
A labeled injectable vitamin product for deficiency-related clinical care, not a blanket energy claim.
FDA-approved product context
A labeled injectable vitamin product for deficiency-related clinical care, not a blanket energy claim.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Evidence and source limits
The retrieved thiamine hydrochloride injection label describes deficiency-related clinical use, including beriberi and Wernicke-Korsakoff context. Its marketing table identifies ANDA215692. Routes and clinical circumstances must be read in the original label.
The label warns of serious hypersensitivity and life-threatening anaphylaxis, with collapse and death reported. An ingredient being a vitamin does not make an injection risk-free.
Approval applies to the specific labeled product, route and indication, not every preparation of this ingredient or a wellness mixture. Read the original full label and discuss individual circumstances with a medical professional. No dosing or preparation instructions are included.
Original source: Thiamine injection (vitamin B1) ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.